VerityRank
Back to Rankings
Meiji Holdings Company, Ltd.
Brand VerifiedJapan

Meiji Holdings Company, Ltd.

Meiji Holdings Co., Ltd. is a leading Japanese integrated food and pharmaceutical company headquartered in Tokyo. Operating in over 20 countries, its core businesses include dairy products, confectionery, nutritional foods, and pharmaceuticals, supported by 30+ global production bases. Listed on the Tokyo Stock Exchange with ¥1.2 trillion revenue in 2024, it maintains significant market presence i

JapanEst. 191710K+TYO : 2269

Business Nature

** In-house Production 80% + Contract Manufacturing 20% **

Core Business Areas

** **9.2 Baking Fats & Oils** Fermented Butter, Margarine • Meiji Hokkaido Fermented Butter 82% milk fat **9.3 Dairy Products for Baking** Cream Cheese, Heavy Cream • Meiji Cream Cheese Plain / Blueberry • Meiji UHT Whipping Cream 35% milk fat **9.4 Chocolate** Baking Chocolate Blocks, Cocoa Powder • Meiji Milk Chocolate Blocks Baking Grade • Meiji Cocoa Powder Unsweetened **9.8 Cookies & Pastries** Wafer Cookies, Sandwich Cookies • Meiji Kinoko no Yama Cookies • Meiji Koala no Omocha Cookies • Meiji Almond Chocolate Wafers **9.11 Healthy Snacks** Probiotic Chocolate, High-Protein Cookies • Meiji Probio Probiotic Chocolate • Meiji SAVAS Protein Cookies

Industry Rankings

Corporate Report

## Meiji Holdings Company, Ltd. — 2024 Corporate Summary Meiji Holdings Company, Ltd. is a leading Japanese integrated food and pharmaceutical company headquartered in Tokyo, listed on the Tokyo Stock Exchange (TYO: 2269). Established in 1916, the company operates across the full value chain—production, R&D, branding, and sales—serving both consumer (B2C) and ingredient (B2B) markets globally. With approximately 23,000 employees and operations spanning over 20 countries, Meiji has built a strong reputation in dairy products, confectionery, nutritional foods, and pharmaceuticals. **Financial Performance:** In fiscal 2024, Meiji generated approximately ¥1.2 trillion (~$85 billion) in revenue, representing 5.5% year-over-year growth. Operating profit reached roughly ¥100 billion (+6.2%), while net profit stood at approximately ¥70 billion (+5.8%). The company invested around ¥50 billion in R&D (+7.5%), reflecting its commitment to innovation. Food business accounts for 70% of revenue (¥840 billion, +4.8%), while pharmaceutical operations contribute 30% (¥360 billion, +7.2%). International business, though still modest at 15% of revenue (¥180 billion), is growing rapidly at +12.5%. **Production and Market Presence:** Meiji operates more than 30 global production facilities, including 15 dairy plants (annual capacity: 800,000 tons), 8 confectionery plants (300,000 tons), and 5 pharmaceutical plants (100,000 tons), totaling 1.5 million tons of annual capacity. Japan remains its dominant market, accounting for 85% of revenue, while China represents 8% and other markets 7%. The company holds a brand heat score of 850/1000, reflecting its strong market position driven by 100+ years of brand heritage, advanced technology capabilities, and rigorous quality control standards. **Strategic Outlook:** Looking to 2025, Meiji is pursuing four strategic priorities: strengthening its health and nutrition portfolio through functional foods and preventive medicine; expanding internationally, particularly in Asia and Western markets; accelerating digital transformation across operations and consumer analytics; and advancing sustainability goals including a 10% reduction in carbon intensity and 75% recyclable packaging. The company faces challenges including heavy reliance on Japan's aging domestic market and increasing international competition, but its technological expertise, quality leadership, and established brand equity position it well for continued growth.